Low-cost personal DNA readings are on the way
By Peter Aldhous,
New Scientist
| 09. 06. 2007
"GENETICS is about to get personal." So proclaims the website of 23andMe, a Californian company that is gearing up to offer people a guided tour of their own DNA. For the superstars of genetics, it has already got personal. Earlier this week, genomics pioneer Craig Venter revealed an almost complete sequence of his genome, while that of James Watson, co-discoverer of DNA's double-helix structure, has been available on the web since late June.
Given that Watson's genome took almost $1 million to read, most of us won't immediately be following in his and Venter's footsteps. It isn't necessary to read your entire genome, however, to browse many of the genetic variations that may influence your health. According to George Church, a geneticist at Harvard Medical School in Boston, the most pertinent information could be gleaned by sequencing the 1 per cent of the genome that codes for proteins. Thanks to the advances in sequencing technology, that might be done for as little as $1000 per person. "DNA chips", meanwhile, can scan your genome for common "spelling mistakes" for...
Related Articles
By Darren Incorvaia, Fierce Biotech | 07.16.2026
Jennifer Doudna, Ph.D., the Nobel Laureate best known for co-inventing the CRISPR system that has become the foundation for gene editing, is dipping her toes into a new, buzzy field: AI-powered protein design.
In a new paper, published today...
By Risa Cromer, The Conversation | 07.17.2026
By Emily Packard Dawson and Lainie Friedman Ross , The Hastings Center for Bioethics | 07.16.2026
Major news outlets recently reported – based on a bioRxiv preprint – that scientists had edited genes in human embryos with “startling precision.” The scientists’ decision to release this work ahead of peer review, coupled with the extensive media coverage...
Media coverage of recent developments in embryo gene editing might seem to suggest that gene-edited babies are close to becoming a reality. As tech billionaires eager to profit off of techno-eugenics invest in “designer baby” technologies, attempts to normalize heritable genome editing – which remains unsafe and raises significant ethical and societal concerns – are especially dangerous. It’s worth taking a closer look at these developments and what they mean, in a way that pushes back on narratives normalizing the...